Found 3 hits Enz. Inhib. hit(s) with Target = 'Orexin receptor type 2' and Ligand = 'BDBM386162' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Orexin receptor type 2
(Homo sapiens (Human)) | BDBM386162
(US10287305, Example 117 | US10508083, Example 117 ...)Show SMILES CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1F |r,wU:21.25,18.18,15.16,9.9,(-2.67,-3.47,;-1.33,-4.23,;,-3.47,;1.33,-4.23,;1.33,-5.78,;2.67,-3.47,;4,-4.23,;5.33,-3.47,;5.33,-1.93,;4,-1.15,;4,.38,;5.33,1.15,;6.67,.38,;4,1.93,;6.42,2.24,;2.67,-1.93,;1.33,-1.15,;1.33,.38,;,1.15,;-1.33,.38,;-2.67,1.15,;-2.67,2.69,;-1.33,3.47,;,2.69,;-4,3.46,;-5.33,2.69,;-6.67,3.46,;-6.67,5,;-5.33,5.78,;-4,5,;-2.67,5.77,)| Show InChI InChI=1S/C22H34FN3O4S/c1-3-24-22(27)26-14-6-9-20(25-31(2,28)29)21(26)15-30-17-12-10-16(11-13-17)18-7-4-5-8-19(18)23/h4-5,7-8,16-17,20-21,25H,3,6,9-15H2,1-2H3,(H,24,27)/t16-,17+,20-,21-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | n/a | n/a | 0.120 | n/a | n/a | n/a | n/a |
AstraZeneca
| Assay Description Chinese hamster ovary (CHO) dhfr-cells forcibly expressing human orexin type 2 receptor (hOX2R) were seeded in each well of Black clear bottom plate ... |
J Med Chem 50: 2213-24 (2007)
BindingDB Entry DOI: 10.7270/Q2Z321Z2 |
More data for this Ligand-Target Pair | |
Orexin receptor type 2
(Homo sapiens (Human)) | BDBM386162
(US10287305, Example 117 | US10508083, Example 117 ...)Show SMILES CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1F |r,wU:21.25,18.18,15.16,9.9,(-2.67,-3.47,;-1.33,-4.23,;,-3.47,;1.33,-4.23,;1.33,-5.78,;2.67,-3.47,;4,-4.23,;5.33,-3.47,;5.33,-1.93,;4,-1.15,;4,.38,;5.33,1.15,;6.67,.38,;4,1.93,;6.42,2.24,;2.67,-1.93,;1.33,-1.15,;1.33,.38,;,1.15,;-1.33,.38,;-2.67,1.15,;-2.67,2.69,;-1.33,3.47,;,2.69,;-4,3.46,;-5.33,2.69,;-6.67,3.46,;-6.67,5,;-5.33,5.78,;-4,5,;-2.67,5.77,)| Show InChI InChI=1S/C22H34FN3O4S/c1-3-24-22(27)26-14-6-9-20(25-31(2,28)29)21(26)15-30-17-12-10-16(11-13-17)18-7-4-5-8-19(18)23/h4-5,7-8,16-17,20-21,25H,3,6,9-15H2,1-2H3,(H,24,27)/t16-,17+,20-,21-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | n/a | n/a | 0.120 | n/a | n/a | n/a | n/a |
TBA
| Assay Description Chinese hamster ovary (CHO) dhfr-cells forcibly expressing human orexin type 2 receptor (hOX2R) were seeded in each well of Black clear bottom plate ... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2CZ3BCW |
More data for this Ligand-Target Pair | |
Orexin receptor type 2
(Homo sapiens (Human)) | BDBM386162
(US10287305, Example 117 | US10508083, Example 117 ...)Show SMILES CCNC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1F |r,wU:21.25,18.18,15.16,9.9,(-2.67,-3.47,;-1.33,-4.23,;,-3.47,;1.33,-4.23,;1.33,-5.78,;2.67,-3.47,;4,-4.23,;5.33,-3.47,;5.33,-1.93,;4,-1.15,;4,.38,;5.33,1.15,;6.67,.38,;4,1.93,;6.42,2.24,;2.67,-1.93,;1.33,-1.15,;1.33,.38,;,1.15,;-1.33,.38,;-2.67,1.15,;-2.67,2.69,;-1.33,3.47,;,2.69,;-4,3.46,;-5.33,2.69,;-6.67,3.46,;-6.67,5,;-5.33,5.78,;-4,5,;-2.67,5.77,)| Show InChI InChI=1S/C22H34FN3O4S/c1-3-24-22(27)26-14-6-9-20(25-31(2,28)29)21(26)15-30-17-12-10-16(11-13-17)18-7-4-5-8-19(18)23/h4-5,7-8,16-17,20-21,25H,3,6,9-15H2,1-2H3,(H,24,27)/t16-,17+,20-,21-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | n/a | n/a | 0.120 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description Chinese hamster ovary (CHO) dhfr-cells forcibly expressing human orexin type 2 receptor (hOX2R) were seeded in each well of Black clear bottom plate ... |
US Patent US10508083 (2019)
BindingDB Entry DOI: 10.7270/Q29S1TD1 |
More data for this Ligand-Target Pair | |